• Welcome Guest
  • View Cart
  • Phone (US): 703.778.3080
  • 0Shopping Cart
  • Market Reports
  • Market Research Subscriptions
    • Knowledge Center
  • Custom Market Research
    • Quantitative Market Research
    • Qualitative Market Research
    • RateMyProduct
  • Blog
  • Featured
    • Free Downloads
    • View Webinars On-Demand
    • The IVD Market in 2023: $130 Billion and Growing
    • The Point of Care Testing Market
    • Immunoassays
  • About Us
    • Contact
  • Search
  • Menu Menu
  • Biotechnology
    • Next Generation Sequencing
    • Proteomics
    • Biopharmaceuticals
    • Instrumentation & Equipment
    • Emerging Technologies
  • Pharmaceuticals
    • Vaccines
    • Drug Delivery
    • Over-the-Counter
    • Drug Discovery
    • Cancer Treatment
    • Manufacturing & Packaging
    • Prescription Drugs
  • Diagnostics
    • Molecular Assays
    • Point-of-Care
    • Immunoassays
    • Infectious Disease
    • Clinical Chemistry
    • Oncology & Hematology
    • Lab Testing Services
    • Medical Imaging
  • Healthcare
    • Information Technology
    • Facilities & Settings
    • Insurance & Managed Care
  • Medical Devices
    • Wound Care
    • Drug Delivery
    • Equipment
    • Surgical
  • Login
Awaiting product image

Filter your search

Search Report Keyword
Price
CATEGORIES
  • Biotechnology Market Research
  • cell and gene therapy
  • cell therapy
  • Diagnostics Market Research
  • gene therapy
  • Healthcare Information Technology
  • Healthcare Market Research
  • in vitro diagnostic
  • IVD
  • life sciences
  • Medical Devices Market Research
  • Molecular & Nucleic Acid Testing
  • Pharmaceuticals Market Research
  • Point-of-Care Diagnostics
  • sciences
  • vaccines

Knowledge Center Sidebar

Most Popular Research

  • Cell and Gene Therapy Business Outlook
  • The Worldwide Market for In Vitro Diagnostic Tests, 14th Edition
  • Clinical Diagnostics MasterFile
  • The Global Market for Medical Devices, 11th Edition
  • The World Market for Molecular Diagnostics Tests, 10th Edition
  • Remote Patient Monitoring and Telehealth Markets, 12th Edition

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications for Immunoassays and Molecular Assays)

$250.00 – $1,600.00

Clear
SKU: KLI2241990 Categories: Diagnostics Market Research, Immunoassays, Infectious Disease, Molecular & Nucleic Acid Testing, Point-of-Care Diagnostics Pages: 60
  • Description
  • Table of Contents
  • Latest reports

Description

The outbreak of H1N1 (swine flu) highlighted the public health importance of improved testing techniques and providing market opportunities for manufacturers of diagnostic tests and other products related to the disease. These conclusions and others appear in a new report released from Kalorama Information: Swine Flu Market Alert by Kalorama’s lead analyst, Shara Rosen.

Regardless of the eventual severity of the epidemic, there will be distinct market impact on both immunoassay and molecular test makers, according to the report. The makers of certain tests will benefit both in terms of sales and more broadly in recognition that their products play a vital role in making the public health community significantly better prepared for this possible pandemic than 1968 or before.

The report examines:

  • Market Impact likely for immunoassays and molecular testing.
  • Lessons from previous epidemics, likely impact on both immunoassays and molecular testing.
  • Overview of the H1N1 strain as compared to other.
  • Immunoassay and Molecular Test Products Available on the Market
  • Developments in the last few days of significance to the diagnostic industry.
  • Profiles of nearly 25 specific manufacturers active in this space.

The report focuses almost exclusively on the in vitro diagnostic industry as it applies to work being done by commercial entities and products that are either in development or have been brought to market.

The market assessment provided has been assembled based on publicly available information. Company sales data and other quantitative evaluations of the markets for flu diagnostics have been developed based on publicly available information and are expressed in US dollars, no adjustments have been made for currency exchange fluctuations.

Under normal circumstances, a report of this genre would be assembled from information derived from primary and secondary sources. However, in the short time it took to research and write this report, almost all of the major scientific and industry experts were occupied with the extraordinary task of preparing for a pandemic.

Therefore the information contained in this report has been assembled from a vast array of scientific and market publications, government sources, analyzed by a professional analyst.

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Background
  • Exhibit 1: Flu Epidemics Compared to Present 1918-Today
  • Scope And Methodology
  • Point of View
  • Information Sources CHAPTER TWO: 2009 SWINE INFLUENZA AND OTHER FLU EPIDEMICS

 

  • Influenza Overview
  • Overview of Virus Types
  • What’s So Special About This Latest Flu?
  • Flu Therapeutics
  • WHO Global Influenza Preparedness Plan

CHAPTER THREE: FLU DIAGNOSTICS

  • Background
  • Exhbit 2: Influenza Test Innovations, 2009 (Company, Technology, Test Details, Status)
  • Immunoassays
    • Rapid Testing
    • Market Performance of Rapid Test
    • New Entrant Possiblity
    • Conclusion: Impact of Swine Flu on Rapid Testing
  • Molecular Assays
    • Molecular Influenza Detection Techniques
    • PCR, Sequencing or Both
    • Lessons and Market Impact of the H5N1 Epidemic

CHAPTER FOUR: PROGNOSIS FOR A/H1N1

  • Background
  • Pandemic – Where? When?
    • 1976 Hsw1N1 Swine Flu Case
    • Comparing Past Flu Epidemics to 2009
    • International Reaction
  • Swine Flu and the IVD Industry
    • Origin of Flu Virus Mixes
    • PCR Test Development
    • Late-Breaking Research Developments
    • Use of Rapid Tests in Current Epidemic

CHAPTER FIVE: COMPANIES AND PRODCUTS IMPACTED BY SWINE FLU EPIDEMIC

  • Immunoassays
    • 3M Medical Diagnostics
    • Becton, Dickinson and Company (BD)
    • Genzyme Corporation
    • Inverness Medical Innovations
    • Meridian Bioscience, Inc.
    • Quidel Corporation
    • Remel, Inc.
    • Response Biomedical Corporation
  • Molecular Tests
    • Arbor Vita Corporation
    • CombiMatrix Molecular Diagnostics (CMDX)
    • Diagnostic HYBRIDS, Inc. (DHI)
    • eGene Inc.
    • Eiken Chemical Co., Ltd
    • Life Technologies/Applied Biosystems/ Invitrogen Corporation (ABI)
    • Lab21
    • Laboratory Corporation of America Holdings (LabCorp)
    • Luminex Corporation
    • Nanogen
    • Prodesse Inc.
    • Qiagen N.V.
    • Seegene Inc.
    • Veredus Laboratories Pte

 

    Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 12th Edition
    May 13, 2025
    In Vitro Diagnostic (IVD) Trends and Market Update, 2025
    April 7, 2025
    In Vitro Diagnostics Business Outlook, 2025 (6 Issues)
    April 3, 2025
    Molecular Diagnostics Quarterly Datastream, 2025
    April 2, 2025

Related products

  • Placeholder image

    Synthetic Blood Substitutes and Blood Products – A Market Briefing

    $995.00 – $1,990.00
  • Placeholder image

    Nucleic Acid-Based Therapeutics: World Markets, Developments, and Applications

    $3,500.00 – $7,000.00
  • Placeholder image

    Blood – The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products

    $1,995.00 – $7,800.00
  • Placeholder image

    Medical Imaging Markets, Volume III – Ultrasound

    $1,200.00 – $5,990.00

Contact Us

  • 671 North Glebe Road, Suite 1610 Arlington, VA 22203 United States

  • Email Us

  • 703-778-3080

  • Send us a message!

Pay Invoice

  • Pay an Invoice by Credit Card

Follow Us!

Latest Blogs

  • 4 Fascinating Facts About Cancer Diagnostics March 4, 2025
  • Food Animal Diagnostics Market: Spotlight on Disease Testing Amid Bird Flu Surge February 20, 2025
  • Custom Competitive Intelligence (CI) Research: A New Strategic Imperative For Lab Diagnostics Companies  February 19, 2025
  • The Rise of Pharmacodiagnostics in the $10 Billion Global Cancer Diagnostics Market February 1, 2025
  • IVD Trends to Watch: Personalized Medicine Adds Precision to Diagnostic Testing January 2, 2025

Sitemap

  • Home
  • About
  • Blog
  • Contact
  • Sitemap

Your Data and Privacy

  • View our Privacy Policy
  • GDPR Statement
  • Privacy Settings

About Us

Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.

Visit Science and Medicine Group
World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, TheHigh-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data...
Scroll to top